Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07408856 · ClinicalTrials.gov registry record · Phase 1
CAN1012 in Pre-Malignant DCIS and LCIS
A Phase 1 study, sponsored by Providence Health & Services.
- Not yet
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT07408856: Clinical Trial Phase 1 study, sponsored by Providence Health & Services.
NCT07408856 is a Phase 1 study that has not yet begun recruiting, run by Providence Health & Services. The registered enrollment target is 24 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07408856, a Phase 1 study, has not yet begun recruiting, sponsored by Providence Health & Services.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a Phase I/Ib study evaluating CAN1012 in patients with ductal carcinoma in situ and lobular carcinoma in situ.
Primary Outcome
Safety will be measured by demonstrating that there is a less than 33% rate of delayed surgery attributable to the study treatment.
Interventions
- DRUG CAN1012
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2026-05 |
| Est. Completion | 2035-05 |
| Phase | Phase 1 |
What is known before NCT07408856 opens enrollment
NCT07408856 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 1 intervention - of which CAN1012 is the first listed.
NCT07408856 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07408856 about?
NCT07408856 is a clinical study titled "CAN1012 in Pre-Malignant DCIS and LCIS". This is a Phase I/Ib study evaluating CAN1012 in patients with ductal carcinoma in situ and lobular carcinoma in situ.
What is the current status of trial NCT07408856?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2026-05. Estimated completion is 2035-05.
What interventions are being tested in trial NCT07408856?
The interventions under investigation include: CAN1012 (DRUG).
Who is sponsoring clinical trial NCT07408856?
This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07408856's enrollment target sits among peer trials
24 1520th of 2000 higher than 405 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia